Active Ingredient(s): Anagrelide
FDA Approved: * March 14, 1997
Pharm Company: * SHIRE
Category: Blood Volume

Anagrelide (Agrylin/Xagrid, Shire and Thromboreductin, AOP Orphan Pharmaceuticals AG) is a drug used for the treatment of essential thrombocytosis (also known as essential thrombocythemia), or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia.[1] Anagrelide controlled release (GALE-401) is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis.[2] Contents 1 Medical us... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Agrylin S063
Agrylin 0.5 mg Oral Capsule
NDC: 54092-063
Shire Us Manufacturing Inc.

Popular Topics

side effects of agrylin

I have been using agrylin for 4 months and suffering from excessive hair lose ## Common side effects of Agrylin are head...